| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 06/07/2001 | WO2001040256A1 Taccalonolides and their use |
| 06/07/2001 | WO2001040214A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040191A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/07/2001 | WO2001039720A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | CA2393056A1 New dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | CA2393026A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | CA2393012A1 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 06/06/2001 | EP1104423A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 06/06/2001 | CN1298398A 12,13-modified epothilone derivatives |
| 06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
| 06/06/2001 | CN1066707C Process for producing 1,2,4,5 pyromellitic anhydride |
| 06/05/2001 | US6242617 Method and device for production of lyophilized hydrochloride-1β, 10β-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 05/31/2001 | WO2000064902A3 Process for the preparation of calanolide precursors |
| 05/30/2001 | EP1032265A4 New psoralens for pathogen inactivation |
| 05/30/2001 | CN1296950A Dioxaspirocyclic compound with unsaturated side chain and its preparing process |
| 05/29/2001 | US6239293 Reacting 2-ketogluonic acid with 2,2-dimethoxypropane in presence of an acid catalyst |
| 05/29/2001 | US6239168 Antitumor agents, immunosuppressants; tyrosine kinase inhibitors |
| 05/25/2001 | WO2001036424A2 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them |
| 05/25/2001 | CA2390109A1 Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing them |
| 05/24/2001 | US20010001800 The xanthene compound reacts with nitric oxide to give a triazole fluorescent compound that emits strong fluorescence by irradiation with excitation light of long wavelength |
| 05/23/2001 | EP1100520A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296487A Dibenzonaphathyrones and their use for colouring/pigmenting high-molecular-weight organic material |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296047A Solidifiable compositions |
| 05/23/2001 | CN1296009A Arteannuin derivant containing azacyclic radical and preparation process thereof |
| 05/23/2001 | CN1296008A Dioxacyclopentedien-6-(5aH)-one compound, its preparation process and medicinal composition |
| 05/22/2001 | US6235808 Radiation-curable cycloaliphatic epoxy compounds, uses thereof, and compositions containing them |
| 05/22/2001 | US6235774 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration |
| 05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | WO2001034609A1 Heterocyclically anellated indenochromene derivatives |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/16/2001 | EP1099730A1 Curable composition |
| 05/16/2001 | EP1098893A1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 05/16/2001 | EP0798288B1 Triciclic compounds |
| 05/15/2001 | US6232331 Benzofuroxan derivatives, their therapeutic uses and pharmaceutical compositions |
| 05/15/2001 | US6232320 Cell adhesion-inhibiting antiinflammatory compounds |
| 05/15/2001 | US6232271 1-Methyl-5-alkylsulfonyl-, 1-methyl-5-alkylsulfinyl- and 1-methyl-5-alkylthio- substituted pyrazolylpyrazoles, processes for their preparation and their use as herbicides |
| 05/10/2001 | WO2001032662A2 Oxygen containing spirocondensed heterocyclic compounds and pharmaceutical compositions comprising same for partial coordination of calcium |
| 05/10/2001 | WO2001032661A1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them |
| 05/10/2001 | WO2001032577A1 Pigmented vitreous material its precursor glass items coated therewith and method of its preparation |
| 05/10/2001 | WO1999002514A3 Epothilone derivatives |
| 05/10/2001 | DE19954229A1 New epothilone derivatives, useful for treating malignant tumors such as ovarian, stomach, colon, breast and lung carcinoma, acute lymphocytic and myelocytic leukemia and chronic inflammatory diseases such as psoriasis |
| 05/10/2001 | CA2389764A1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them |
| 05/10/2001 | CA2325271A1 Curable composition |
| 05/09/2001 | EP1097156A2 Phtochromic benzopyrano-fused naphthopyrans |
| 05/09/2001 | EP1097155A2 Photochromic six-membered heterocyclic-fused naphthopyrans |
| 05/09/2001 | EP0749432B1 9-deoxotaxane compounds |
| 05/08/2001 | US6229055 Synthesis of fluorinated xanthene derivatives |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6228653 Reagent for immunoassays; has high thermal stability and high quantum efficiency for high emission |
| 05/08/2001 | US6228020 Compliant hearing aid |
| 05/03/2001 | WO2001030776A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same |
| 05/03/2001 | WO2001030736A2 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
| 05/03/2001 | WO2001030734A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 05/03/2001 | WO2001007439A3 Process for the production of epothiolone b and derivatives as well as intermediate products for this process |
| 05/03/2001 | CA2389169A1 Novel limonoids for use particularly in the treatment of cancer and method for producing the same |
| 05/02/2001 | EP1095940A2 Derivatives of 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-one, method for their preparation and pharmaceutical compositions containing them |
| 05/02/2001 | EP1095043A1 Trioxane derivatives |
| 05/02/2001 | EP1095042A1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 05/02/2001 | EP1095041A2 Dibenzonaphthyrones and their use for colouring/pigmenting high-molecular-weight organic material |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | CN1065277C Process for preparation of avermectins |
| 05/01/2001 | US6225478 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 05/01/2001 | US6225466 For articles made of synthetic resin materials; rapid darkening and brightening rates, durability |
| 05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
| 05/01/2001 | CA2085703C 13-(substituted thio) acetoxymilbemycin derivatives, their preparation and their agrochemical uses |
| 04/28/2001 | CA2324495A1 New 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro ¢3',4':6,7!-naphto ¢2,3-d! ¢1,3! dioxol-6(5ah)-one derivatives, their preparation process and pharmaceutical compositions containing them |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones |
| 04/25/2001 | CN1292683A Compositions containing organic compounds |
| 04/25/2001 | CN1292375A O-acyl-alpha-hydroxycarboxylic ester compound and its preparation method |
| 04/24/2001 | US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
| 04/24/2001 | US6221937 Mixtures; photostability, heat and oxidation resistance; for polymers |
| 04/24/2001 | US6221872 Debrominating a pyrrole; fusing the product with an amidine; condensing the product with a nucleophile; reducing and purifying |
| 04/24/2001 | US6221153 Dissolving compound selected from taxoid or brystatin in solvent; mixing with critical, supercritical or near critical fluid to form solution comprising fluid solvent and compound; precipitating compound as needle like crystal |
| 04/24/2001 | CA2021881C Process for preparing lankacidine carbamate derivatives |
| 04/19/2001 | WO2001027309A1 Hiv integrase inhibitors |
| 04/19/2001 | WO2001027308A2 13-alkyl epothilone derivatives |
| 04/19/2001 | WO2001027145A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 04/19/2001 | WO2001027115A1 Pentacyclic taxane compounds |
| 04/19/2001 | DE19949284A1 Chirale Verbindung und deren Verwendung als chirale Dotierstoffe zur Herstellung von cholesterisch-flüssigkristallinen Zusammensetzungen Chiral compound and their use as chiral dopants for the production of cholesteric liquid crystal compositions |
| 04/19/2001 | CA2425620A1 13-alkyl epothilone derivatives |
| 04/18/2001 | EP1092721A1 Chiral glucosides and their use as chiral dopants for the production of cholesteric liquid crystalline compositions |
| 04/18/2001 | EP1091978A2 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 04/17/2001 | US6218405 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 04/17/2001 | US6218135 Easy to handle, heat stable, and high in emission efficiency; for immunoassays |
| 04/17/2001 | US6218100 Eliminating viral disease transmission through blood products via said compositions which have ability to inactivate pathogens in presence of ultaviolet light without effecting blood product functioning or exhibiting mutagenicity |
| 04/17/2001 | US6217792 Chiral dopants |
| 04/12/2001 | WO2001025240A1 HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |